论文信息 - Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014 - 字舞流文

Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014

Y. Hosomi | M. Shibuya | K. Sakamaki | N. Seki | H. Kunitoh | F. Oshita | Kouzo Yamada | H. Okamoto | Koshiro Watanabe | Y. Okuma | Y. Miura | A. Satoh | K. Minato | N. Hida | M. Yomota | Takahiko Sakamoto | Y. Takagi | H. Aono